BIOSPRING PARTNERS — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services.
BiotechDeep TechHealthtechMedical Devices
Geoffrey Glass(Founding CEO)in
Co-investorsWelsh, Carson, Anderson & StoweWCAS
ixlayer provides a platform that connects biopharma companies with patients, labs, providers, and payment systems to deploy personalized patient experience programs powered by AI.
AI & Machine LearningDigital HealthHealthtechSaaS
Pouria Sanae(Co-founder and Chief Executive Officer)Poorya Sabounchi(Co-founder and Chief Operating Officer)
Co-investorsInitiate Venture PartnersNimble PartnersXYZ Venture CapitalMBX Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.